Global Compression Therapy Market Outlook 2030

  • Product Code:
    RP-ID-10059300
  • Published Date:
    14 Sep 2021
  • Region:
    Global
  • Pages:
    144
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-12

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

ccs

Market Overview:

By 2021, the global compression therapy market was valued at ~USD 4 billion and is expected to grow at a CAGR of ~6% during the forecast period 2022-2030. The increasing prevalence of venous diseases (such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and thrombosis) is a high-impact rendering engine. Products, especially stockings and bandages, are increasingly used to treat the aforementioned diseases, thereby promoting growth. According to the Department of Vascular Surgery, approximately 50% of people have chronic venous abnormalities

The potential benefits associated with the application of these products in the treatment of targeted diseases, such as reduced leg and foot volume, venous reflux and high blood pressure, are expected to drive demand during the forecast period. In addition, the availability of various alternatives or methods from bandages and stockings to pneumatic devices to achieve effective treatment provides a variety of options for patients with different conditions.

Due to the significant increase in the number of global accidents and the obese population, the market is mainly driven by more and more orthopedic surgeries. The growing elderly population is extremely vulnerable to orthopedic diseases, leading to a large number of orthopedic surgeries. These factors have led to an increase in product consumption. According to data from the American Academy of Orthopaedic Surgeons in 2006, knee and hip replacements are expected to increase by 673% and 174%, respectively, in the next 20 years.

This unprecedented growth in orthopedic surgery reflects the demand for products. In addition, compression therapy is often used in plastic surgery to relieve pain, reduce swelling, and promote rapid recovery of function. The above-mentioned advantages are mainly related to the high permeability of related products in the treatment of musculoskeletal injuries, which have been successively used in orthopedic surgery.

The increasing application of pressure suits in sports medicine is expected to provide profitable growth opportunities for the market. Compression therapy is increasingly used to prevent inflammation and swelling after injury or trauma. These products are also widely used to increase blood circulation in the body, prevent the liquid in the tissue space from clotting, thereby promoting muscle health.

TECHNICAL INSIGHTS:

Static technology dominated the technical field in 2020 because of its great convenience and user-friendly features. A large part of the market segment is attributable to the easier availability of these products in the treatment of edema and sports-related injuries to reduce pain and stress. The benefits associated with static technology are also believed to drive the tendency of patients and doctors to dominate. In addition, the majority of the market segment;s share is considered to be the result of the increasing susceptibility of diabetic patients.

The elderly population is based on lymphedema, deep vein thrombosis and chronic venous insufficiency. In addition, there are organizations that are constantly striving to increase the level of awareness related to their availability in certain indications. For example, according to the National Medical Policy of Health Net, Inc., a government health insurance provider recommends refractory lymphedema of the arm caused by mastectomy for breast cancer.

Dynamic technology is expected to grow exponentially during the forecast period due to related benefits, and it is considered a more appropriate choice in the future. These benefits include external control, high venous return, and sustained action. In addition, more and more healthcare professionals are recommending the use of dynamic technology, which is expected to increase. For example, in 2008, the American College of Physicians conducted research on antithrombotic treatments for venous thromboembolic diseases and achieved positive results.

PRODUCT INFORMATION:

In 2020, the leading share of bandages in the product segment exceeded 45%. The above is considered to be the result of its high adoption in the treatment of lower extremity edema and venous and lymphatic system diseases. The advantages of high-strength sustainability, high cost efficiency, malleability and elasticity of bandages are considered to be the reasons why they are widely used in various venous diseases. In order to meet the requirements of patients and obtain better results, stretching and short-term stretching are leading to high segmented market growth. Bandages are considered the gold standard for the treatment of lymphedema. The occurrence of most vascular diseases led to the absorption of these bandages, which contributed to the dominant participation in 2016.

Due to the increasing number of cases of lymphedema and other venous diseases, compression pumps are expected to show a significant compound annual growth rate in the next few years. In addition, the pump is designed to facilitate the delivery of controlled pressure based on the severity of the disease, making it more effective compared to other alternatives.

In addition, according to the Journal of the American Medical Association (JAMA) Journal of Dermatology, the use of pumps can significantly reduce hospital stays, cellulitis infections, and outpatient visits. In addition, more and more pumps are used as conservative measures to replace failures. In some cases, non-programmable single- and multi-chamber lymphedema pumps are patients who do not respond to traditional options (such as compression garments). These options are considered medically necessary in the treatment of lymphedema and venous ulcers.

REGIONAL INFORMATION:


North America occupied a dominant share of the general market in 2020. The growth of the elderly population and the high incidence of chronic venous diseases and obesity accounted for the share achieved in the region in previous years. The existence of favorable government reimbursement programs and increased levels of health care awareness are also key factors that promote the growth of the region, as well as the presence of a large number of established pharmaceutical companies, who are constantly striving to achieve extensive marketing and expand your geographic coverage, which is very important. It is a key factor in the rapid growth of the region.

Due to the burden of chronic disease targets in the United States, the United States accounted for the largest share of the compression therapy market in North America in 2020, which promotes the urgency of clinical use of compression products. According to a study published in NCBI, it is reported that the prevalence of chronic venous disease is highest in Western countries, with 15.0% to 40.0% in women and 1.0% to 17.0% in men. A lucrative growth rate throughout the forecast period. The market is driven by large R&D investments by major players and consistent measures to sell products at relatively low prices. In addition, the increase in disposable income has increased the possibility of using these products, and the continuous improvement of medical infrastructure is expected to provide the market with opportunities for revenue growth.

During the forecast period, Japan has a considerable share of the Asia-Pacific compression therapy market. Presumably, this is the result of technological innovation, growing cooperation among global players, and the expansion of the distribution network for its main products (such as compression pumps).

COMPRESSION THERAPY MARKET SHARE INFORMATION:

Some of the major players are Medi GmbH & Co., Paul Hartmann AG, Julius Zorn GmbH, ArjoHuntleigh, SIGVARIS, Medtronic Plc and BSN Medical GmbH. These players are implementing regional and distribution channel expansion, new product development and collaboration strategies to gain greater market share. In addition, major players are increasingly inclined to maintain competition through outsourcing.

Manufacturers are constantly striving to establish production facilities in emerging economies to reduce production costs and take advantage of untapped opportunities. For example, BSN Medicals acquired FarrowMed Medical Solutions in June 2015. This acquisition aims to promote BSN Medicals expansion of lymphedema treatment solutions and provide a competitive advantage in the treatment of lymphedema and venous diseases.

MARKET SEGMENTS COVERED BY THE REPORT :

This report forecasts revenue growth at the global, regional, and country levels, and analyzes industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research has broken down the global compression therapy market report based on technology, product and region: technology outlook (revenue, millions of dollars, 2022-2030) static compression therapy dynamic compression therapy product outlook (income , Millions of dollars, 2022-2030) compression pump compression stockings compression stockings compression belt.

"


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

1 INTRODUCTION OF GLOBAL COMPRESSION THERAPY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL COMPRESSION THERAPY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL COMPRESSION THERAPY MARKET, BY PRODUCT:
5.1 Compression Garments
5.1.1 Compression Stockings
5.1.2 Compression Bandages & Wraps
5.1.3 Other Compression Garments
5.2 Compression Pumps
5.3 Compression Braces

6 GLOBAL COMPRESSION THERAPY MARKET, BY APPLICATION:
6.1 Varicose Vein Treatment
6.2 Deep Vein Thrombosis Treatment
6.3 Lymphedema Treatment
6.4 Leg Ulcer Treatment
6.5 Other Applications

7 GLOBAL COMPRESSION THERAPY MARKET, BY TECHNIQUE:
7.1 Static Compression Therapy
7.2 Dynamic Compression Therapy

8 GLOBAL COMPRESSION THERAPY MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 – 2025

9 GLOBAL COMPRESSION THERAPY MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 3M Company
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Medtronic PLC
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Bio Compression Systems, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 BSN Medical
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Medi GmbH & Co. Kg
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Paul Hartmann AG
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Smith & Nephew PLC.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Cardinal Health, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Sigvaris
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Sanyleg S.R.L.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Tactile Medical
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Convatec Inc.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 DJO Global Inc.
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Arjohuntleigh
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Julius Zorn GmbH
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

11 Appendix
11.1 Related Reports

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports